Antiproliferative effect of peripheral benzodiazepine receptor antagonist PK11195 in rat mammary tumor cells

Molecular and Cellular Biochemistry

Volumn 340, Issue 1-2, 2010, Pages 203-213

  Mukhopadhyay, Sutapa ^a   Guillory, Bobby ^a   Mukherjee, Shyamali ^a   Das, Salil K ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Breast tumor cells; Peripheral benzodiazepine receptors; PK11195; Rats

Indexed keywords

ANTIBODY; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BETA ACTIN; CARCINOGEN; CASEIN; CD31 ANTIBODY; CYCLINE; DIMETHYLBENZ[A]ANTHRACENE; LIPOCORTIN 5; MONOCLONAL ANTIBODY KI 67; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RO5 4864; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4'-CHLORODIAZEPAM; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; BZRP PROTEIN, RAT; CARRIER PROTEIN; CD31 ANTIGEN; ISOQUINOLINE DERIVATIVE; KI 67 ANTIGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER GRADING; CELL DIFFERENTIATION; CELL INVASION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; NONHUMAN; RAT; TUMOR CELL; TUMOR CELL CULTURE; WOUND CLOSURE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CYCLE; CELL MOTION; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; EXPERIMENTAL MAMMARY NEOPLASM; METABOLISM; PATHOLOGY; PHENOTYPE; SPRAGUE DAWLEY RAT; TIME; TUMOR INVASION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANNEXIN A5; ANTIGENS, CD31; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZODIAZEPINONES; CARRIER PROTEINS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; ISOQUINOLINES; KI-67 ANTIGEN; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM INVASIVENESS; PHENOTYPE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; TIME FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; GABA-A RECEPTOR AGONISTS; GABA-A RECEPTOR ANTAGONISTS;

RATTUS;

EID: 77954424202     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0419-4     Document Type: Article

References (65)

1. J Papadimitriou-Taylor M Stampfer J Bartek A Lewis M Boshell EB Lane IM Leigh 1989 Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium J Cell Sci 94 403 413
2. HM McDiarmid GR Douglas BL Coomber PD Josephy 2002 2-amino-1-methyl-6- phenylimidezo [4, 5-b]pyridine (PhIP)-induced mutagenesis in cultured Big Blue rat mammary epithelial and fibroblast cells Environ Mol Mutagen 39 245 253 10.1002/em.10059 1:CAS:528:DC%2BD38Xis1WmtL0%3D 11921195 (Pubitemid 34260499)
3. Ries L, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK (eds) (2007) SEER Cancer Statistics Review, 1975-2004, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975-2004/, posted to the SEER Web site
4. A Beurdeley-Thomas L Miccoli S Oudard B Dutrillaux MF Poupon 2000 The peripheral benzodiazepine receptors: a review J Neurooncol 46 45 56 10.1023/A:1006456715525 1:STN:280:DC%2BD3M%2FhtlalsQ%3D%3D 10896204 (Pubitemid 30352611)
5. Y Katz G Ben-Baruch Y Kloog J Menczer M Gavish 1990 Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries Clin Sci (Lond) 78 155 158 1:STN:280:DyaK3c7otlagsg%3D%3D
6. I Venturini H Alho I Podkletnova L Corsi E Rybnikova R Pellicci M Baraldi M Pelto-Huikko P Helen ML Zeneroli 1999 Increased expression of peripheral benzodiazepine receptors and diazepam binding inhibitor in human tumors sited in the liver Life Sci 65 2223 2231 10.1016/S0024-3205(99)00487-7 1:CAS:528:DyaK1MXmvVyit7s%3D 10576594 (Pubitemid 29524872)
7. N Miyazawa E Hamel M Diksic 1998 Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods J Neurooncol 38 19 26 10.1023/A:1005933226966 1:STN:280:DyaK1c3gtVyktA%3D%3D 9540054
8. S Mukhopadhyay S Mukherjee SK Das 2006 Increased expression of peripheral benzodiazepine receptor (PBR) in dimethylbenz[a]anthracene-induced mammary tumors in rats Glycoconj J 23 199 207 10.1007/s10719-006-7925-3 1:CAS:528:DC%2BD28XksFShu7c%3D 16691503 (Pubitemid 43725199)
9. K Maaser AP Sutter A Krahn M Hopfner P Grabowski H Scherubl 2004 Cell cycle-related signaling pathways modulated by peripheral benzodiazepine receptor ligands in colorectal cancer cells Biochem Biophy Res Commun 324 878 886 10.1016/j.bbrc.2004.09.127 1:CAS:528:DC%2BD2cXotlCmt74%3D (Pubitemid 39345597)
10. I Carmel FA Fares S Leschiner H Scherübl G Weisinger M Gavish 1999 Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line Biochem Pharmacol 58 273 278 10.1016/S0006-2952(99)00093-3 1:CAS:528:DyaK1MXktVSjsrg%3D 10423168 (Pubitemid 29255945)
11. M Landau A Weizman E Zoref-Shani E Beery L Wasseman O Landau M Gavish S Brenner J Nordenberg 1998 Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells Biochem Pharmacol 56 1029 1034 10.1016/S0006-2952(98)00149-X 1:CAS:528:DyaK1cXmsVyqsrw%3D 9776314 (Pubitemid 28454568)
12. K Maaser M Hopfner A Jansen G Weisinger M Gavish AP Kozikowski A Weizman P Carayon EO Riecken M Zeitz H Scherubl 2001 Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells Br J Cancer 85 1771 1780 10.1054/bjoc.2001.2181 1:CAS:528:DC%2BD38XnsVCgtg%3D%3D 11742501 (Pubitemid 34081526)
13. AP Sutter K Maaser M Hopfner B Barthel P Grabowski S Faiss P Carayon M Zeitz H Scherubl 2002 Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells Int J Cancer 102 318 327 10.1002/ijc.10724 1:CAS:528:DC%2BD38Xos1ajtL8%3D 12402299 (Pubitemid 35265870)
14. A Beinlich R Strohmeier M Kaufmann H Kuhl 1999 Specific binding of benzodiazepines to human breast cancer cell lines Life Sci 65 2099 2108 10.1016/S0024-3205(99)00475-0 1:CAS:528:DyaK1MXmvFegtbo%3D 10579463 (Pubitemid 29524859)
15. JT Neary SL Jorgensen AM Oracion JH Bruce MD Norenberg 1995 Inhibition of growth factor-induced DNA synthesis in astrocytes by ligands of peripheral-type benzodiazepine receptors Brain Res 675 27 30 10.1016/0006-8993(95)00031-K 1:CAS:528:DyaK2MXksVyltbc%3D 7796139
16. SL Ratcliffe EK Matthews 1995 Modification of the photodynamic action of delta-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands Br J Cancer 71 300 305 1:CAS:528: DyaK2MXksFeju74%3D 7841044
17. L Kupczyk-Subotkowska TJ Siahaan AS Basile HS Friedman PE Higgins D Song JM Gallo 1997 Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate J Med Chem 40 1726 1730 10.1021/jm960592p 1:CAS:528:DyaK2sXjtFSjtLY%3D 9171882 (Pubitemid 27231475)
18. L and Mcl-1 expressing human cholangiocarcinoma cells Gut 51 556 561 10.1136/gut.51.4.556 1:CAS:528:DC%2BD3sXhslWmt7w%3D 12235080
19. B Chelli A Salvetti E DaPozzo M Rechichi F Spinetti L Rossi B Costa A Lena G Rainaldi F Scatena R Vanacore V Gremigni C Martini 2008 PK11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells J Cell Biochem 105 712 723 10.1002/jcb.21865 1:CAS:528:DC%2BD1cXht1Ojsr7K 18668527
20. P Casellas S Galiegue AS Basile 2002 Peripheral benzodiazepine receptors and mitochondrial function Neurochem Int 40 475 486 10.1016/S0197-0186(01)00118- 8 1:CAS:528:DC%2BD38XhtFyktLs%3D 11850104 (Pubitemid 34159148)
21. RA Gonzalez-Polo G Carvalho T Braun D Decaudin C Fabre N Larochette JL Perfettini M Djavaheri-Mergny I Youlyouz-Marfak P Codogno M Raphael J Feuillard G Kroemer 2005 PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor Oncogene 24 7503 7513 10.1038/sj.onc.1208907 1:CAS:528:DC%2BD2MXht1WktrzP 16091749 (Pubitemid 41638026)
22. KM Darcy D Zangani AL Wohlhueter RY Huang MM Vaughan JA Russell MM Ip 2000 Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells J Histochem Cytochem 48 63 80 1:CAS:528:DC%2BD3cXntFCqsA%3D%3D 10653587
23. JR Laduca DK Sinha 1996 Tumorigenesis of rat mammary epithelial cells by N-nitroso-N-methylurea in an in vitro system: characterization of the microtumors In Vitro Cell Dev Biol Anim 32 204 210 10.1007/BF02722947 1:CAS:528:DyaK28Xjslejsbw%3D 8727044
24. JA Zwiebel MR Davis E Kohn DS Salomon WR Kidwell 1982 Anchorage-independent growth-conferring factor production by rat mammary tumor cells Cancer Res 42 5117 5125 1:CAS:528:DyaL3sXhsV2rtA%3D%3D 6291748
25. SP Ethier BC Langton CA Dilts 1996 Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha Mol Carcinog 15 134 143 10.1002/(SICI)1098-2744(199602)15:2<134::AID-MC6>3.0. CO;2-J 1:CAS:528:DyaK28Xht1Krurs%3D 8599580 (Pubitemid 26088827)
26. S Mukhopadhyay BR Ballard S Mukherjee SM Kabir SK Das 2006 Beneficial effects of soy protein in the initiation and progression against dimethylbenz[a]anthracene-induced breast tumors in female rats Mol Cell Biochem 290 169 176 10.1007/s11010-006-9184-9 1:CAS:528:DC%2BD28XhtVSitb3I 16941229 (Pubitemid 44473248)
27. Darcy KM, Zangani D, Lee PH, Ip MM (2000) Isolation and culture of normal rat mammary epithelial cells. In: Ip MM, Asch (eds) Methods in mammary gland biology and breast cancer research. Kluwer/Plenum Publishers, New York, pp 163-176
28. IJ Fidler 1990 Critical factors in the biology of human cancer metastasis: twenty-eighth GHA Clowes memorial award lecture Cancer Res 50 6130 6138 1:STN:280:DyaK3czotFKrsA%3D%3D 1698118
29. W Auerbach R Auerbach 1994 Angiogenesis inhibition: a review Pharmacol Ther 63 265 311 10.1016/0163-7258(94)90027-2 1:CAS:528:DyaK2cXmslWjtrY%3D 7530374 (Pubitemid 24315751)
30. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other diseases Nat Med 1 27 31 10.1038/nm0195-27 1:CAS:528:DyaK2MXjs1KnsLk%3D 7584949
31. IJ Fiddler 1995 Modulation of the organ microenvironment for the treatment of cancer metastasis J Natl Cancer Inst 84 1588 1592
32. DV Parums JL Cordell F Micklem AR Heryet KC Gatter DY Masons 1990 JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections J Clin Pathol 43 752 757 10.1136/jcp.43.9.752 1:STN:280:DyaK3M%2FgvF2iug%3D%3D 2212067
33. A Giatromanolaki MI Koukourakis K O'Byrne L Kaklamanis C Dicoglou E Trichia R Whitehouse AL Harris KC Gatter 1996 Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis Anticancer Res 16 3819 3825 1:STN:280:DyaK2s7psVyhtA%3D%3D 9042264 (Pubitemid 27085055)
34. ER Horak R Leek N Klenk S LeJeune K Smith N Stuart M Greenall K Stepniewska AL Harris 1992 Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer Lancet 340 1120 1124 10.1016/0140-6736(92)93150-L 1:STN:280:DyaK3s%2FmtFGgsw%3D%3D 1279332
35. Y Takebayashi S Akiyama S Akiba K Yamada K Miyadera T Sumizawa Y Yamada F Murata T Aikou 1996 Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma J Natl Cancer Inst 88 1110 1117 10.1093/jnci/88.16.1110 1:CAS:528:DyaK28Xlslyhurc%3D 8757190
36. PL Fitzgibbons DL Page D Weaver AD Thor DC Allred GM Clark SG Ruby F O'Malley JF Simpson JL Connolly DF Hayes SB Edge A Lichter SJ Schnitt 2000 Prognostic factors in breast cancer Arch Pathol Lab Med 124 966 978 1:STN:280:DC%2BD3czptVKrtQ%3D%3D 10888772
37. CD Archer M Patron IE Smith PA Ellis J Salter S Ashley G Gui N Sacks SR Ebbs W Allum N Nasiri M Dowsett 2003 Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer Br J Cancer 89 1035 1041 10.1038/sj.bjc.6601173 1:CAS:528:DC%2BD3sXntVKgurg%3D 12966422 (Pubitemid 37239208)
38. T Petit M Wilt M Velten R Millon JF Rodier C Borel R Mors P Haegelé M Eber JP Ghnassia 2004 Comparative value of tumor grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy Eur J Cancer 40 205 211 10.1016/S0959-8049(03)00675-0 1:CAS:528:DC%2BD2cXjsVOlsA%3D%3D 14728934 (Pubitemid 38077022)
39. S Aaltomaa P Lipponen K Syrjanen 1993 Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer Anticancer Res 13 533 538 1:STN:280:DyaK3s3pslyruw%3D%3D 8100128
40. Y Kudo I Ogawa M Kitagawa S Kitajima S Siriwardena N Aobara C Matsuda M Miyauchi T Takata 2006 Establishment and characterization of a spindle cell squamous carcinoma cell line J Oral Pathol Med 35 479 483 10.1111/j.1600-0714. 2006.00446.x 1:CAS:528:DC%2BD28XhtV2rtr7E 16918599 (Pubitemid 44212902)
41. DG Johnson CL Walker 1999 Cyclins and cell cycle checkpoints Annu Rev Pharmacol Toxicol 39 295 312 10.1146/annurev.pharmtox.39.1.295 1:CAS:528:DyaK1MXjtVejtL8%3D 10331086 (Pubitemid 29222561)
42. M Toi H Bando T Ogawa M Muta C Hornig HA Weich 2002 Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer Int J Cancer 98 14 18 10.1002/ijc.10121 1:CAS:528: DC%2BD38Xht1WgsLo%3D 11857378 (Pubitemid 34113411)
43. G Gasparini 2000 Prognostic value of vascular endothelial growth factor in breast cancer Oncologist 5 37 44 10.1634/theoncologist.5-suppl-1-37 1:CAS:528:DC%2BD3cXjsFartrY%3D 10804090
44. B Linderholm B Lindh B Tavelin K Grankvist R Henriksson 2000 p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma Int J Cancer 89 51 62 10.1002/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.0.CO;2-8 1:CAS:528:DC%2BD3cXhsVGqsLk%3D 10719731 (Pubitemid 30078750)
45. U Eppenberger W Kueng JM Schlaeppi JL Roesel C Benz H Mueller A Matter M Zuber K Luescher M Litschgi M Schmitt JA Foekens S Eppenberger-Castori 1998 Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients J Clin Oncol 16 3129 3136 1:STN:280:DyaK1cvgvV2ltw%3D%3D 9738585
46. G Gasparini M Toi M Gion P Verderio R Dittadi M Hanatani I Matsubara O Vinante E Bonoldi P Boracchi C Gatti H Suzuki T Tominaga 1997 Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma J Natl Cancer Inst 89 139 147 10.1093/jnci/89.2.139 1:STN:280:DyaK2s7lt1amsw%3D%3D 8998183
47. C Schlüter M Duchrow C Wohlenberg MH Becker G Key HD Flad J Gerdes 1993 The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins J Cell Biol 123 513 522 10.1083/jcb.123.3.513 8227122 (Pubitemid 23324910)
48. Tavassoli FN (1992) Pathology of the breast. Appleton and Lange, Norwalk, p 548
49. JS Chu CS Huang KJ Chang 1998 Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan Cancer Lett 131 145 152 10.1016/S0304-3835(98)00118-9 1:CAS:528:DyaK1cXnslOnsLY%3D 9851246 (Pubitemid 28479782)
50. SR Tahan DS Neuberg A Dieffenbach L Yacoub 1993 Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score Cancer 71 3552 3559 10.1002/1097-0142(19930601)71: 11<3552::AID-CNCR2820711115>3.0.CO;2-N 1:STN:280:DyaK3s3lvVOgsA%3D%3D 8098267 (Pubitemid 23152664)
51. T Tsurimoto 1998 PCNA, a multifunctional ring on DNA Biochim Biophys Acta 1443 23 39 1:CAS:528:DyaK1cXns1KlsLo%3D 9838028
52. M Oshimura JC Barrett 1986 Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer Environ Mutagen 8 129 159 10.1002/em.2860080112 1:CAS:528:DyaL28Xht1Cgsrk%3D 3510860 (Pubitemid 16173597)
53. DW Visscher RJ Jarbo G Jacobsen A Kambouris G Talpos W Sakr JD Crissman 1990 Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations Lab Invest 62 370 378 1:STN:280:DyaK3c7ovFOrsQ%3D%3D 1690316
54. TW Chung SK Moon YC Chang JH Ko YC Lee G Cho SH Kim JG Kim CH Kim 2004 Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism FASEB J 18 1670 1681 10.1096/fj.04-2126com 1:CAS:528: DC%2BD2cXpslGrsrw%3D 15522912 (Pubitemid 39463706)
55. MJ Hendrix EA Seftor RE Seftor IJ Fidler 1987 A simple quantitative assay for studying the invasive potential of high and low human metastatic variants Cancer Lett 38 137 147 10.1016/0304-3835(87)90209-6 1:STN:280: DyaL1c%2FnvF2muw%3D%3D 3690504 (Pubitemid 18005844)
56. A Albini Y Iwamoto HK Kleinman GR Martin SA Saronson JM Kozlowski RN McEwan 1987 A rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Res 47 3239 3245 1:STN:280:DyaL2s3hsFKhtQ%3D%3D 2438036
57. VP Terranova ES Hujanen DM Loeb GR Martin L Thornburg V Glushko 1986 Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells Proc Natl Acad Sci USA 83 465 469 10.1073/pnas.83.2.465 1:STN:280:DyaL28%2FpsVCisw%3D%3D 3455782
58. M Hardwick D Fertikh M Culty H Li B Vidic V Papadopoulos 1999 Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol Cancer Res 59 831 842 1:CAS:528:DyaK1MXht1Sju7c%3D 10029072
59. A Camins C Diez-Fernandez E Pujadas J Camarasa E Escubedo 1995 A new aspect of the antiproliferative action of peripheral-type benzodiazepine receptor ligands Eur J Pharmacol 272 289 292 10.1016/0014-2999(94)00652-N 1:CAS:528:DyaK2MXjt1Smsrk%3D 7713173
60. M Pawlikowski J Kunert-Radek A Radek H Stepien 1988 Inhibition of cell proliferation of human gliomas by benzodiazepines in vitro Acta Neurol Scand 77 231 233 10.1111/j.1600-0404.1988.tb05900.x 1:CAS:528:DyaL1cXitFGqtLc%3D 3132026
61. J Kunert-Radek H Stepien M Pawlikowski 1994 Inhibition of rat pituitary tumor cell proliferation by benzodiazepines in vitro Neuroendocrinology 59 92 96 10.1159/000126644 1:CAS:528:DyaK2cXhvVamt7o%3D 8145899 (Pubitemid 24026921)
62. D Clarke PJ Ryan 1980 Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells Nature 287 160 161 10.1038/287160a0 1:CAS:528:DyaL3MXktFWlsA%3D%3D 6933311 (Pubitemid 11227693)
63. DE Banker JJ Cooper DA Fennell C Willman FR Appelbaum FE Cotter 2002 PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents, by mitochondrial and non-mitochondrial mechanisms Leuk Res 26 91 106 10.1016/S0145-2126(01)00112-6 1:CAS:528:DC%2BD3MXovVekur8%3D 11734307 (Pubitemid 33085505)
64. S Shimizu M Narita Y Tsujimoto 1999 Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC Nature 399 483 487 10.1038/20959 1:CAS:528:DyaK1MXjvV2ju7o%3D 10365962 (Pubitemid 29258855)
65. T Hirsch D Decaudin SA Susin P Marchetti N Larochette M Resche-Rigon G Kroemer 1998 PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection Exp Cell Res 241 426 434 10.1006/excr.1998.4084 1:CAS:528:DyaK1cXktVSht78%3D 9637784 (Pubitemid 28366568)